Pfizer Should Outperform, Morgan Stanley Upgrades By: Benzinga via Benzinga September 20, 2017 at 09:45 AM EDT Analysts at Morgan Stanley turned bullish on Pfizer Inc. (NYSE: PFE) amid multiple catalysts and accretive M&A opportunities ... Read More >> Related Stocks: Pfizer